Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowHII to Participate in Bernstein’s 42nd Annual Strategic Decisions Conference on May 28
Just nowExpensify and VAT IT Launch Integration Partnership to Simplify Global VAT Reclaim
Just nowUnited Maritime Reports Improved First Quarter 2026 Financial Results and Declares Quarterly Cash Dividend of $0.10 Per Share
1m agoData I/O to Present at the Planet MicroCap Investor Conference Powered by MicroCapClub
1m agoRapid7 Q1 2026 Threat Landscape Report Finds Vulnerability Exploitation Overtakes Social Engineering as the Top Initial Access Vector
Inflarx N.v. logo

Inflarx N.v.

About

2.44USD+0.07 +2.95%
Closed • Updated at 13:37 GMT+00:00
Market Cap$176.39M
Volume777.0K
Beta2.16
RSI64.55
Health TechnologyBiotechnology

Inflarx N.v. — investor relations, events, news, and company updates on 6ix.

Latest News

May 8 2026
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares
May 6 2026
InflaRx Announces Pricing of $150 Million Underwritten Offering of Ordinary Shares
May 4 2026
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes
May 1 2026
InflaRx to Report First Quarter 2026 Results on May 7, 2026
Apr 9 2026
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor

Community Chat

Ask AI

6ix6ixAIEvents